Intermittent hypoxia in sleep-disordered breathing as a potential modifier of carcinogenic processes: a hypothesis-driven framework
Frontiers in Oncology · 20.11.2026 · 16
DOI: 10.3389/fonc.2026.1959571 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 20.11.2026. Verfasst von Carlos Mas Bermejo und 2 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Intermittent hypoxia is a defining physiological feature of sleep-disordered breathing, characterized by repetitive cycles of oxygen desaturation and reoxygenation during sleep. Unlike sustained hypoxia, intermittent hypoxia generates a distinct biological stress profile capable of activating oxidative, inflammatory, metabolic, and immune-modulatory pathways with potential systemic consequences. Emerging evidence suggests that the cumulative hypoxic burden, rather than traditional event-based metrics, may better capture the biological relevance of nocturnal oxygen instability.
Objective
To propose a hypothesis-driven conceptual framework positioning intermittent hypoxia arising from sleep-disordered breathing as a systemic biological modifier with potential relevance to carcinogenic processes.
Methods
This article presents an integrative, hypothesis-based synthesis of experimental, mechanistic, and clinical literature. Targeted searches of PubMed and Scopus were conducted to identify representative studies addressing intermittent hypoxia, hypoxia-inducible signaling, oxidative stress, immune modulation, metabolic reprogramming, and cancer-related outcomes in the context of sleep-disordered breathing. Evidence was selected based on mechanistic plausibility and translational relevance rather than systematic criteria.
Results
Experimental models demonstrate that intermittent hypoxia activates hypoxia-inducible factor signaling, promotes oxidative stress, alters immune surveillance, and induces metabolic adaptations consistent with pro-tumorigenic environments. Clinical and epidemiological studies further suggest associations between sleep-disordered breathing severity—particularly hypoxic burden—and cancer incidence or progression. These converging data support the concept that intermittent hypoxia functions as a systemic stressor capable of modulating biological pathways implicated in carcinogenesis.
Conclusions
Intermittent hypoxia should be considered more than a downstream consequence of sleep-disordered breathing. This hypothesis-driven framework positions nocturnal hypoxic burden as a biologically active exposure with potential implications for cancer susceptibility and disease modulation. Recognizing intermittent hypoxia as a modifiable systemic stressor may open new avenues for interdisciplinary research at the interface of sleep medicine and oncology.
Zitieren
APA
Bermejo, C. M., Gómez, C. M., & Bravo-González, L. (2026). Intermittent hypoxia in sleep-disordered breathing as a potential modifier of carcinogenic processes: a hypothesis-driven framework. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1959571
Vancouver
Bermejo CM, Gómez CM, Bravo-González L. Intermittent hypoxia in sleep-disordered breathing as a potential modifier of carcinogenic processes: a hypothesis-driven framework. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1959571
BibTeX
@article{Bermejo2026,
author = {Bermejo, Carlos Mas and Gómez, Carlos Mas and Bravo-González, Luis-Alberto},
title = {Intermittent hypoxia in sleep-disordered breathing as a potential modifier of carcinogenic processes: a hypothesis-driven framework},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1959571}
}
EUVIMED